CREST: phase III study of sasanlimab and Bacillus Calmette-Gu érin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer

Future Oncology, Ahead of Print.

Source: Future Oncology - January 8, 2024 Category: Cancer & Oncology Authors: Gary D Steinberg Neal D Shore Joan Palou Redorta Matthew D Galsky Jens Bedke Ja Hyeon Ku Michal Kretkowski Hailong Hu Konstantin Penkov Jennifer J Vermette Jamal C Tarazi Alison E Randall Kristen J Pierce Daniel Saltzstein Thomas B Powles Source Type: research